Sodium Chloride and Contrast Nephropathy

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 271 participants.

Also called NCT03476460

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 2
Enrolled
  • 271 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03476460
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Spain (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03476460. Randomized; no masking; primary purpose prevention. Start 2014-04-01 (actual); primary completion 2019-11-29 (actual). Results posted on 2025-03-20.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Sodium Chloride and Contrast Nephropathy
Acronym
PNIC-Na
Condition
Kidney Failure, Chronic
Condition
Kidney Failure, Acute
Condition
Heart Failure
Condition
Diabetes
Intervention (Drug)
Oral sodium chloride
Intervention (Drug)
Intravenous sodium chloride
Lead sponsor
Hospital Universitario Ramon y Cajal (class: other)
Collaborator
Instituto de Salud Carlos III (class: other government)
Collaborator
Ministerio de Sanidad, Servicios Sociales e Igualdad (class: other government)

Record details

Record id
cardio:ct-nct03476460
Content hash
7ff7b1fd2de18dcc8b31ba97ea7f40780d95bef0362ad493087d17b4b508fd4d